Dizal Pharmaceuticals

Works in Hematology · Immunology · Oncology · Respiratory

Dizal Pharmaceuticals is a clinical trial sponsor. It has 18 active clinical trials with 3,871 planned participants, in Hematology, Immunology, Oncology and Respiratory. Since 2021 it has completed 16 trials and stopped 2 early.

Trial track record · since 2021

18Active trials3,871 planned participants
16Completed2 with results posted
2Stopped early11% of finished trials

Pipeline · 18 active trials

StageTrialStatus

On the market

1 approved drug application with a product on the market.

Questions about Dizal Pharmaceuticals

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.

Approve Suite is not affiliated with Dizal Pharmaceuticals.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.